
Dr. Matthias Eiber from the department of radiology at Technische Universität München reports that from a minimal clinical study they have determined that advantageous use of FDG-PET/MRI imaging modalities to detect bone lesions, rather than PET/CT modalities. Their work is published in the Journal of Nuclear Medicine.